
Surgical snake technology developer Medrobotics Corp. closed a $11.7 million Series C funding round led by current shareholders, angel investors and the Pittsburgh Life Sciences Greenhouse.
Medrobotics, originally known as Cardiorobotics, has raised $28.3 million since it spun out of Carnegie Mellon University in 2005.
The Boston, Mass.-based med-tech maker’s robots allow surgeons to perform 2-handed surgeries in hard-to-reach anatomical areas. The robots can support their own weight and move in any 3D space without structural support.
Sign up to get our free newsletters delivered right to your inbox
Along with its $11.7 million funding round, Medrobotics also took in $6.48 million of a total $10 million debt offering late last month.
Medrobotics plans to file for U.S. commercial approval for its surgical snake in 2012.

Here’s a roundup of other dealflow and investment news:
Titan Medical closes unit offering
Toronto, Ontario-based Titan Medical Inc. sold 4.8 million shares at $1.55 each during a pursuant offering for $7.5 million. Read more
Boston-based health care investor Excel Venture Management seeks to raise up to $150 million for a second fund, according to an SEC filing. Read more
Thoratec Corp. entered into a $50 million credit facility with Wells Fargo Bank, National Association. The facility will be available to Thoratec on a revolving basis until Dec. 2016. Read more
Spine device maker InVivo Therapeutics Holdings entered into a securities purchase agreement with Ingenieria E Inversiones for $2 million. Read more
Digital diagnostics platform designer Pinpoint MD is nearing its $1.5 million fresh capital funding goal. Sixteen investors have contributed $1.43 million, according to a government filing. Read more
Bio implant maker MiMidx Group Inc. completed a $5 million private placement offering to sell convertible notes and warrants. Read more
HIV test maker Daktari Diagnostics Inc. closed a $5 million equity round led by Partners Innovation Fund, Launchpad Venture Group, Hub Angels Investment Group and Boston Harbor Angels. Read more
Minnesota-based KSpine raised $2.5 million to continue the development of its spinal implant to treat scoliosis. The implant requires a less invasive surgical procedure than typical methods. Read more
Vascular Solutions Inc. entered into the second amendment to promissory note and credit agreement to extend the term of the agreement to December 31, 2012. Read more